Tesla’s (NASDAQ:TSLA) stock has faced continued pressure in 2025, but Wedbush remains bullish, maintaining an Outperform rating and a $550 price target. Key Takeaways from Wedbush Report DOGE & ...
Dan Ives, Wedbush Securities global head of technology research and senior equity analyst, joins 'Squawk Box' to discuss ...
Ford CEO Jim Farley has repeatedly told Wall Street that Ford will bring smaller, affordable - yet profitable - EVs to market ...
New York State Teachers Retirement System decreased its position in shares of Healthcare Realty Trust Incorporated (NYSE:HR – ...
New York State Teachers Retirement System trimmed its position in shares of Cathay General Bancorp (NASDAQ:CATY – Free Report ...
Wedbush Securities analyst Dan Ives remains bullish on Tesla, maintaining his $550 price target despite growing concerns over ...
Denny's (NASDAQ:DENN) rallied on Friday after Wedbush Securities fired off an upgrade on the restaurant stock to an Outperform rating from the prior rating of Neutral. Analyst Nick Setyan and his ...
There’s a good chance the phone you want to buy is already in the United States, whether it’s a new device sitting ... of technology research at Wedbush Securities. “I mean, right now ...
Your next smartphone might be more expensive because of President Donald Trump’s recently imposed 10% tariff on Chinese ...
Wedbush analyst David Nierengarten maintained a Buy rating on Oric Pharmaceuticals (ORIC – Research Report) today and set a price target of $20.00. The company’s shares closed yesterday at $12 ...
and other professionals at the Securities Enforcement Forum New York 2025 (the Forum), held on January 28, 2025, in Manhattan—just days after President Donald Trump was inaugurated. Panelists ...